```html

Pathologic Nipple Discharge – A Comprehensive Medical Guide

Overview

Pathologic nipple discharge (PND) is the spontaneous, unilateral or bilateral flow of fluid from one or both nipples that is not related to normal physiologic causes such as breastfeeding, pregnancy, or hormonal medication. Unlike the milky, clear, or translucent discharge that can occur during lactation, PND is typically unilateral, may be serous, bloody, or colored (green, yellow, or black), and often persists despite manipulation of the breast.

PND can affect women of any age but is most common in women ages 30–50 years. It accounts for roughly 2–5% of all breast‑clinic visits and is the presenting symptom in 1–3% of breast cancers (Mayo Clinic, 2023). Though men can develop nipple discharge, it is exceedingly rare (<1% of cases) and usually signals an underlying pathology that warrants prompt evaluation.

Symptoms

Patients with pathologic nipple discharge may notice one or more of the following:

• Spontaneous discharge – fluid appears without pressure or pumping.
• Unilateral involvement – most often affects only one breast; bilateral discharge should still be evaluated.
• Color/appearance – serous (clear), bloody, brown, green, yellow, or milky (non‑lactating).
• Consistency – thin watery fluid or thicker, mucous‑like secretion.
• Duration – may be intermittent or constant; chronic discharge lasting >2 weeks is concerning.
• Associated breast changes – palpable lump, skin retraction, nipple inversion, or ulceration.
• Pain or tenderness – some patients report mild discomfort.
• Systemic symptoms – rarely, fever or malaise if an infection (e.g., mastitis) is present.

Any bloody, colored, or persistent discharge should be considered pathologic until proven otherwise.

Causes and Risk Factors

Pathologic nipple discharge is a symptom, not a disease itself. It can arise from a variety of benign and malignant conditions.

Benign causes

• Ductal ectasia – dilation of the subareolar ducts, often producing a thick, greenish discharge; most common in perimenopausal women.
• Intradenal papilloma – a small, benign tumor within a milk duct; frequently causes serous or bloody discharge.
• Fibrocystic changes – hormonal fluctuations leading to cyst formation; may produce occasional discharge.
• Infection (mastitis or breast abscess) – especially in lactating women, but can occur in non‑lactating patients with skin breaks.
• Hormonal medications – oral contraceptives, hormone replacement therapy, or certain antipsychotics (e.g., risperidone) can stimulate secretion.
• Galactorrhea – hyperprolactinemia from pituitary adenoma, hypothyroidism, or drugs (e.g., metoclopramide).
• Trauma or recent surgery – duct injury can cause temporary discharge.

Malignant causes

• Ductal carcinoma in situ (DCIS) – accounts for up to 5% of PND cases.
• Invasive ductal carcinoma – especially when a tumor involves the nipple‑areolar complex.
• Paget disease of the nipple – rare, presents with eczematous changes and discharge.

Risk factors for malignant PND

• Age > 40 years
• Family history of breast or ovarian cancer
• Personal history of breast cancer or high‑risk lesions (e.g., atypical hyperplasia)
• BRCA1/BRCA2 or other pathogenic gene mutations
• Radiation exposure to the chest (e.g., prior therapeutic radiation)
• Long‑term hormone replacement therapy

Diagnosis

Because PND can be the first sign of breast cancer, a systematic evaluation is essential.

Clinical assessment

• History – onset, duration, color, laterality, associated breast symptoms, medication list, hormonal status, and family cancer history.
• Physical exam – inspection of the nipple/areola, palpation for masses, skin changes, and assessment of axillary lymph nodes.

Imaging studies

• Diagnostic mammography (full‑field) – first‑line for women ≥30 y; detects microcalcifications, masses, or ductal changes.
• Breast ultrasound – useful for dense breasts and for characterizing cystic vs. solid lesions.
• Magnetic resonance imaging (MRI) – indicated when mammography/ultrasound are inconclusive or when high‑risk cancer is suspected.
• Ductography (galactography) – contrast injection into the discharging duct; visualizes intraductal lesions such as papillomas.

Pathologic sampling

• Fine‑needle aspiration (FNA) of discharge – cytology can detect malignant cells; sensitivity is modest (≈30‑50%).
• Core needle biopsy of any associated mass or suspicious ductal area.
• Excisional surgical biopsy – removal of the involved duct(s) when imaging is negative but suspicion remains.

Laboratory evaluation

• Serum prolactin level – to rule out hyperprolactinemia.
• Thyroid‑stimulating hormone (TSH) – hypothyroidism can elevate prolactin.
• Pregnancy test – to exclude lactational causes.

Guidelines from the American College of Radiology (ACR) and the National Comprehensive Cancer Network (NCCN) recommend a stepwise approach: start with clinical exam → diagnostic mammogram ± ultrasound → targeted ductography if discharge persists without an obvious lesion (Mayo Clinic, 2022).

Treatment Options

Treatment is directed at the underlying cause. Management may range from observation to surgery.

Benign conditions

• Observation – asymptomatic duct ectasia with clear discharge can be monitored.
• Medication adjustment – discontinue prolactin‑elevating drugs or switch hormonal therapy.
• Medical therapy
  • Cabergoline or bromocriptine for hyperprolactinemia (dose titrated to normalize prolactin).
  • Antibiotics for bacterial mastitis (e.g., dicloxacillin 500 mg QID for 10 days).
• Minimally invasive procedures
  • Image‑guided duct excision (micro‑ductectomy) for isolated papilloma.
  • Laser or radiofrequency ablation of benign intraductal lesions (emerging data, see JAMA Surg 2023).

Malignant or high‑risk lesions

• Surgical excision – central lumpectomy or total mastectomy depending on tumor size, location, and patient preference.
• Sentinel lymph node biopsy – for invasive cancers.
• Adjuvant therapy – radiation, chemotherapy, HER2‑targeted agents, or hormonal therapy as indicated (NCCN Breast Cancer Guidelines 2024).
• Reconstruction – immediate or delayed breast reconstruction after mastectomy, discussed with a plastic surgeon.

Lifestyle and supportive measures

• Warm compresses to alleviate discomfort.
• Supportive bras to minimize friction on the nipple.
• Education on proper breast self‑examination.

Living with Pathologic Nipple Discharge

Even after a diagnosis is made and treatment initiated, many patients experience ongoing concerns. Here are practical tips for daily life:

Self‑monitoring

• Keep a discharge diary—note color, amount, and any triggers (e.g., menstrual cycle, medication changes).
• Perform a monthly breast self‑exam; report any new lumps, skin changes, or worsening discharge.

Skin and nipple care

• Gentle cleansing with mild, fragrance‑free soap; pat dry.
• Apply a thin layer of **hypoallergenic petroleum jelly** to prevent cracking if the nipple is irritated.
• Avoid harsh adhesives, tight bras, or friction‑inducing fabrics.

Emotional wellbeing

• Join a support group (e.g., Breastcancer.org forums) – sharing experiences reduces anxiety.
• Consider counseling if the discharge affects body image or sexual intimacy.

Follow‑up care

• Adhere to the imaging schedule recommended by your provider (usually mammogram + ultrasound every 6–12 months for the first 2 years after treatment).
• Report any new or changing discharge immediately, even if routine follow‑up is not due.

Prevention

Because PND can be the first sign of an underlying disease, true primary prevention is limited. However, risk can be lowered by:

• Maintaining a healthy weight and regular exercise – reduces estrogen excess.
• Limiting alcohol intake to ≤1 drink/day (or none).
• Using the lowest effective dose of hormonal contraceptives and discussing alternatives with a provider.
• Regular breast cancer screening per age‑specific guidelines (annual mammography beginning at age 40 for average risk, earlier for high‑risk individuals).
• Prompt treatment of breast infections and avoidance of nipple trauma.
• Monitoring medication side‑effects; ask your doctor about alternatives if a drug is known to raise prolactin.

Complications

If left untreated, pathologic nipple discharge can lead to serious outcomes:

• Delayed cancer diagnosis – a missed malignancy may progress to invasive disease, reducing survival rates.
• Chronic infection or abscess formation – especially when discharge is related to duct blockage.
• Psychological distress – anxiety, depression, and impaired quality of life.
• Skin breakdown – persistent moisture can cause maceration, dermatitis, or secondary bacterial infection.
• Breast deformity – surgical excision of ducts may lead to nipple retraction or volume loss if not reconstructed.

When to Seek Emergency Care

---

References

• Mayo Clinic. “Nipple discharge: When is it a problem?” Updated 2023. https://www.mayoclinic.org
• American College of Radiology (ACR) Breast Imaging Reporting and Data System (BI-RADS), 2022.
• National Comprehensive Cancer Network. “Breast Cancer (Version 5.2024).” NCCN Guidelines.
• Cleveland Clinic. “Pathologic Nipple Discharge.” 2022. https://my.clevelandclinic.org
• World Health Organization. “Global Cancer Observatory: Breast Cancer Factsheet.” 2023.
• JAMA Surgery. “Radiofrequency ablation of intraductal papilloma: a multicenter prospective study.” 2023;158(9):847‑855.
• U.S. Preventive Services Task Force. “Breast Cancer Screening Guidelines.” 2024.

```